Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
J Saudi Heart Assoc ; 35(4): 279-289, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-38116404

RESUMEN

Introductions: The awareness of brain death and heart donation (HD) among the Saudi population remains limited, coupled with negative attitudes toward heart donation, resulting in a significant gap between the demand for donor hearts and the available supply. This study aimed to comprehensively understand the current perceptions, attitudes, and practices of the Saudi population regarding HD, as well as identify the obstacles. The ultimate goal was to strengthen the local donor pool. Methods: A cross-sectional study was conducted from March to May 2023, employing a self-administered internet survey. The survey collected demographic information, assessed awareness, attitudes, and practices related to HD, and was completed by 1820 participants from various regions in Saudi Arabia. Data was analyzed using SPSS version 25 (SPSS Inc., Chicago, Illinois, USA). Chi-square test, Independent-samples t-test, one way analysis of variance test (ANOVA) and Spearman correlation coefficient was performed with the significance level set at p < 0.05. Results: A significant portion of the population (out of 1820 participants) lacked organ donation cards and were uncertain about the registration process. Participants displayed a moderate level of knowledge about HD, with roughly half holding unfavorable attitudes toward HD. A considerable percentage of participants 62.0% were unwilling to register as heart donors, but a majority (79.9%) were willing to contribute by disseminating information about HD. The study identified significant associations between knowledge scores and several factors, including age (p = 0.002), career (p = 0.000), possession of an organ donation card (p = 0.000), and a history of transplantation or organ donation among relatives (p = 0.000). A significant relationship was observed between attitude scores and several factors, including career (p = 0.001), Saudi region (p = 0.025), possession of an organ donation card (p = 0.000), and a history of transplantation or organ donation among relatives (p = 0.000). Conclusion: The study highlights the urgent need for increased awareness to bolster the number of local heart donors. The involvement of healthcare professionals and social campaigns is essential to enhance public knowledge and potentially boost the willingness of individuals to become donors.

3.
Genet Test Mol Biomarkers ; 26(7-8): 398-407, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36027040

RESUMEN

Background: Diabetes mellitus is a known risk factor for stroke and may be linked to poorer post-stroke outcomes. However, the underlying molecular mechanisms remain to be fully identified. In this study we assessed the association of the lncRNA Nuclear enriched abundant transcript 1 (NEAT1)'s expression and its target miRNA-124 with acute ischemic stroke (AIS) in type II diabetic patients (T2DM). Methods and Results: Diabetic patients with stroke, non-diabetics with stroke, diabetics without stroke, and controls were recruited. NEAT1 and miR-124 expression levels in plasma samples from the participants were investigated using real-time reverse transcription-polymerase chain reaction (RT-qPCR). C reactive protein (CRP) and tumor necrosis factor alpha (TNF-α) were measured using an enzyme linked immunosorbent assay (ELISA) technique. In the DM+AIS group, NEAT1 expression was considerably higher, compared with AIS group and with control group. In comparison to the AIS-only patients, DM patients and controls, miR-124 expression was considerably lower in the DM+AIS group. NEAT1 was shown to have good predictive value for AIS risk in diabetics, based on Receiver Operating Characteristic (ROC) curve analysis. In both the DM+AIS and the AIS group, NEAT1 levels was strongly linked with the National Institutes of Health Stroke Scale (NIHSS) score. Also, a significant positive correlation was observed between NEAT1 expression and the inflammatory markers CRP and TNF-α and significant negative association with miRNA-124 in patient groups. Conclusion: In diabetic patients, the lncRNA NEAT1 may influence the incidence, severity, inflammation, and prognosis of AIS. NEAT1 expression levels could be used as a diagnostic marker of stroke in diabetic patients.


Asunto(s)
Diabetes Mellitus , Accidente Cerebrovascular Isquémico , MicroARNs , ARN Largo no Codificante , Proteína C-Reactiva , Estudios de Casos y Controles , Diabetes Mellitus/genética , Humanos , Accidente Cerebrovascular Isquémico/genética , MicroARNs/genética , ARN Largo no Codificante/genética , Factor de Necrosis Tumoral alfa
4.
J Gene Med ; 21(11): e3128, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31693774

RESUMEN

BACKGROUND: Previous studies have suggested a strong genetic effect on sepsis pathogenesis. The present study aimed to investigate the role of miRNA-146-a expression in pediatric sepsis. METHODS: The study included 55 pediatric sepsis patients and 60 control children of the same age and sex. Serum miRNA-146-a expression was measured using a quantitative real-time polymerase chain reaction. C-reactive protein, interleukin-6, tumor necrosis factor-α and procalcitonin levels were measured by an enzyme-linked immunosorbent assay. The outcome of the pediatric sepsis group was determined at 28 days of follow up. RESULTS: The results obtained revealed that serum miRNA-146-a levels were significantly decreased in sepsis group compared to the control group. Serum level of miRNA-146a correlated with sepsis severity, with the pediatric septic shock group having the lowest level, followed by the severe sepsis and sepsis groups. The miRNA-146-a level could indicate sepsis (area under curve = 0.803). Serum miRNA-146-a expression was negatively associated with C-reactive protein, pro-calcitonin, interleukin-6 and tumor necrosis factor-α. Patients with miRNA-146-a at a level lower than 0.4 had an increased mortality rate. CONCLUSIONS: miRNA-146-a is of significant diagnostic and prognostic value in pediatric sepsis and could be used for planning therapeutic strategies.


Asunto(s)
Biomarcadores , MicroARN Circulante , MicroARNs/genética , Sepsis/diagnóstico , Sepsis/genética , Proteína C-Reactiva , Niño , Preescolar , MicroARN Circulante/sangre , Citocinas/sangre , Egipto , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Lactante , Mediadores de Inflamación/sangre , Unidades de Cuidado Intensivo Pediátrico , Masculino , MicroARNs/sangre , Pronóstico , Curva ROC , Sepsis/sangre , Sepsis/mortalidad
5.
Clin Biochem ; 68: 30-36, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30981701

RESUMEN

BACKGROUND: MicroRNAs (miRNAs) are emerging gene expression regulators and their expression has been linked to various biological processes. However, the role of miRNAs in the regulation of allergic inflammatory disease still not clearly understood. AIM: Our study was designed to investigate circulating miR-155 and Let-7a expression levels in the plasma of asthmatic children and healthy controls. Also, to correlate their expression levels to degree of severity of asthma as well as to IL-13 level and lung function parameters. METHOD: Our study included 100 asthmatic children and 100 healthy children as control group. Plasma miR-155 and Let-7a expression levels were measured by quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS: MicroRNA-155 expression was significantly increased in the plasma of asthmatic children than in control children. While, Let-7a expression was significantly lower in asthmatics than in control children. The relative levels of miR-155 and Let-7a were associated with degree of asthma severity. Receiver operating characteristic (ROC) curve analysis demonstrated that the levels of miR-155 and Let-7a were helpful for diagnosis of childhood asthma (AUC were 0.91 and 0.92, respectively), and in prediction of the severity of disease (AUC were 0.83 and 0.80, respectively). Plasma miRNA-155 was correlated positively with Il-13 levels and correlated negatively with FEV1and FVC. While, Let-7a was correlated negatively with Il-13 and correlated positively with FEV1 and FVC. CONCLUSION: MicroRNA-155 and let-7a could be used as serological non-invasive biomarkers for diagnosis of asthma and degree of severity. Our results could be used for exploring the pathogenesis of asthma and help in selecting promising therapeutic modalities.


Asunto(s)
Asma/genética , MicroARNs/genética , Biomarcadores/metabolismo , Regulación de la Expresión Génica/genética , Humanos , Curva ROC
6.
J Cell Biochem ; 120(5): 8581-8587, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30485512

RESUMEN

Many tumor-suppressor genes contain CpG islands in their promoter regions which raised the necessity of investigating the role of methylation in silencing these genes. We examined p16 methylation as a potential biomarker in the peripheral blood of colorectal cancer (CRC) patients. Using methylation-specific polymerase chain reaction method, the methylation status of p16 was investigated in the tumor tissue and blood of 65 CRC patients and blood samples from 70 healthy control individuals. Also, the relationship between p16 methylation level and the clinical-pathological findings in CRC was evaluated. The frequency of blood p16 methylation in CRC cases was significantly higher than in control (P = 0.0001). The sensitivity and specificity of p16 methylation in diagnosing CRC was 55.38% and 98.5%, respectively, with 77.7% diagnostic accuracy. There was significant association between p16 methylation and age, sex, Dukes staging, lymph node involvement, and carcinoembryonic antigen levels. Our study revealed that p16 promoter methylation could be considered as both potential diagnostic and prognostic biomarker of CRC.

7.
Gene ; 667: 56-61, 2018 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-29758297

RESUMEN

Diabetic foot ulcers are one of the most common complications of diabetes with high morbidity and mortality. Negative pressure wound therapy (NPWT) is one of the treatment modalities that facilitates the wound healing process; however, its molecular mechanism remains unclear. The aim of this study was to investigate the mechanism of action of NPWT in the treatment of diabetic foot ulcers via measuring the tissue expression of genes related to the wound healing process. The study included 40 patients with diabetic foot ulceration, 20 of them received NPWT and the other 20 were a control group treated with advanced moist therapy. Granulation tissue biopsies were obtained before and 10 days after treatment in both groups and subjected to real-time polymerase chain reaction to measure the mRNA expression of TGF-ß1, VEGF, TNF-α, IL-1ß, MMP-1, MMP-9 and TIMP-1 which are involved in the wound healing pathway. After 10 days of treatment with NPWT, the mRNA levels of IL-1ß, TNF-α, MMP-1, and MMP-9 were significantly downregulated, while the levels of VEGF, TGF-ß1 and TIMP-1 were significantly increased. Our study demonstrated that NPWT promotes wound healing in diabetic foot ulcers possibly by affecting growth factors, inflammatory cytokines, and matrix metalloproteinases.


Asunto(s)
Pie Diabético/genética , Pie Diabético/terapia , Perfilación de la Expresión Génica/métodos , Marcadores Genéticos , Terapia de Presión Negativa para Heridas/métodos , Anciano , Femenino , Regulación de la Expresión Génica , Humanos , Interleucina-1beta/genética , Masculino , Metaloproteinasa 1 de la Matriz/genética , Metaloproteinasa 9 de la Matriz/genética , Persona de Mediana Edad , Inhibidor Tisular de Metaloproteinasa-1/genética , Factor de Crecimiento Transformador beta1/genética , Factor de Necrosis Tumoral alfa/genética , Factor A de Crecimiento Endotelial Vascular/genética
8.
Anat Rec (Hoboken) ; 301(8): 1454-1466, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29575794

RESUMEN

Zinc oxide nanoparticles (ZnONPs) are widely used in the last decades. Therefore, investigation of its neurotoxic effect is important. This work aimed to investigate the potential adverse effects of ZnONPs on rat's cerebellar cortex and the possible neuroprotective role of curcumin (Cur). Forty male albino rats were randomly divided into four equal groups. Two groups were injected with ZnONPs and one group was previously received Cur before ZnONPs. At the end of the experiment, cerebellar tissue samples were prepared for histological, morphometric, immunohistochemical study, and tissue levels of oxidative stress markers and cytokine analysis. cerebellar damage is clearly visible with ZnONPs. Degeneration, loss, disorganization of cerebellar neurons was observed. Histopathological degeneration of Purkinje and granular cells together with loss of Nissl substance, astrocyte gliosis, and affection of cerebellar blood brain barrier were detected. Moreover, an apoptotic marker (caspase-3) was significantly expressed in Purkinje and granular layers together with elevated gene expression of P53 and COX-2 in cerebellar tissue of ZnONPs intoxicated group. Astrocyte gliosis and inflammatory markers IL-1, IL-6, and TNF-α were expressed significantly in ZnONPs intoxicated cerebellum. These changes were associated with evidence of cerebellar oxidative stress. Strikingly, treatment with Cur together with ZnONPs recorded morphological improvement, with increased number of Purkinje cells and decreased caspase +ve cells. These findings were confirmed by morphometric and statistical analysis. Cur ameliorates the deterious effect of ZnONPs on the cerebellar cortex through its antioxidant, antiapoptotic, and anti-inflammatory efficacies. Anat Rec, 2018. © 2018 Wiley Periodicals, Inc.


Asunto(s)
Antioxidantes/farmacología , Corteza Cerebelosa/efectos de los fármacos , Curcumina/farmacología , Nanopartículas/toxicidad , Estrés Oxidativo/efectos de los fármacos , Óxido de Zinc/toxicidad , Animales , Corteza Cerebelosa/metabolismo , Corteza Cerebelosa/patología , Masculino , Fármacos Neuroprotectores/farmacología , Estrés Oxidativo/fisiología , Distribución Aleatoria , Ratas
9.
Gene ; 654: 87-94, 2018 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-29452233

RESUMEN

Generation of new ß cells is an important approach in the treatment of type 1 diabetes mellitus (type 1 DM). Adipose tissue-derived stem cells (ADSCs) might be one of the best sources for cell replacement therapy for diabetes. Therefore, this work aimed to test the possible role of transplanted insulin-producing cells (IPCs) differentiated from ADSCs in treatment of streptozotocin (STZ) induced type I DM in rats. Type 1 DM was induced by single intra peritoneal injection with STZ (50 mg/kg BW). Half of the diabetic rats were left without treatment and the other half were injected with differentiated IPCs directly into the pancreas. ADSCs were harvested, cultured and identified by testing their phenotypes through flow cytometry. They were further subjected to differentiation into IPCs using differentiation medium. mRNA expression of pancreatic transcription factors (pdx1), insulin and glucose transporter-2 genes by real time PCR was done to detect the cellular differentiation and confirmed by stimulated insulin secretion. The pancreatic tissues from all groups were examined 2 months after IPC transplantation and were subjected to histological, Immunohistochemical and morphometric study. The differentiated IPCs showed significant expression of pancreatic ß cell markers and insulin secretion in glucose dependent manner. Treatment with IPCs induced apparent regeneration, diffused proliferated islet cells and significant increase in C-peptide immune reaction. We concluded that transplantation of differentiated IPCs improved function and morphology of Islet cells in diabetic rats. Consequently, this therapy option may be a promising therapeutic approach to patient with type 1 DM if proven to be effective and safe.


Asunto(s)
Tejido Adiposo/citología , Diabetes Mellitus Experimental/terapia , Diabetes Mellitus Tipo 1/terapia , Células Secretoras de Insulina/trasplante , Insulina/metabolismo , Células Madre/citología , Animales , Glucemia/análisis , Péptido C/inmunología , Diferenciación Celular , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 1/metabolismo , Transportador de Glucosa de Tipo 2/metabolismo , Proteínas de Homeodominio/metabolismo , Insulina/sangre , Células Secretoras de Insulina/metabolismo , Islotes Pancreáticos/citología , Islotes Pancreáticos/metabolismo , Trasplante de Islotes Pancreáticos/métodos , Masculino , Dominios Proteicos , Ratas , Transactivadores/metabolismo
10.
Cancer Genet ; 220: 32-37, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-29310836

RESUMEN

The abnormal contribution of long non-coding RNA (lncRNAs) expression to human tumorigenesis is still a matter of debate. Breast cancer is the most common cancer in females; it represents a terrible problem in our country. The aim of this research was to assess the role of MALAT1, as one of lncRNAs, as a potential biomarker in breast cancer. This study comprised 80 patients with breast cancer and 80 controls. MALAT1 expression was measured by RT-quantitative polymerase chain reaction (qPCR). CA15-3 was estimated using chemiluminescence immunoassay (CLIA). MALAT1 expression was significantly elevated in breast cancer cases compared to controls (P < 0.0001). By performing the ROC curve analysis, we assumed that the diagnostic sensitivity and specificity for breast cancer were 83.7% and 81.2%, respectively for MALAT1 expression and 77.5% and 82.5% respectively for CA15-3 level. Moreover, combination analysis of the 2 parameters improved the diagnostic sensitivity of CA15-3 in breast cancer. In conclusion, MALAT1 expression level was positively correlated with lymph node status, estrogen receptor (ER), tumor stage and histological grade indicating its possible prognostic value. MALAT1 expression can be used as an accurate marker for diagnosis of breast cancer, in addition it possesses a prognostic value of such disease.


Asunto(s)
Neoplasias de la Mama/sangre , Neoplasias de la Mama/genética , ARN Largo no Codificante/sangre , Biomarcadores de Tumor/biosíntesis , Biomarcadores de Tumor/sangre , Biomarcadores de Tumor/genética , Estudios de Casos y Controles , Egipto , Femenino , Humanos , Persona de Mediana Edad , Pronóstico , ARN Largo no Codificante/biosíntesis , ARN Largo no Codificante/genética
11.
Biochem Cell Biol ; 95(4): 474-481, 2017 08.
Artículo en Inglés | MEDLINE | ID: mdl-28273427

RESUMEN

Although genetics plays an essential role in the pathogenesis of vitiligo, vitiligo pathogenesis is still unclear. Our aim was to investigate the role of IFN-γ expression and polymorphism in vitiligo susceptibility and whether intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor (TNF)-α, and TNF-ß play a role in vitiligo pathogenesis as important inflammatory parameters. Eighty-five patients with vitiligo and 90 controls were investigated for IFN-γ gene expression by quantitative real-time PCR and genotyped for IFN-γ +874T/A (rs2430561) and IFN-γ +2109A/G (rs1861494) gene polymorphisms by sequence-specific primer (SSP)-PCR and PCR-restriction fragment length polymorphism (RFLP), respectively. Serum levels of inflammatory parameters were measured using ELISA. Frequencies of the +874 TT genotype and T allele were significantly higher in patients with active vitiligo than in stable patients (P = 0.01 and 0.03, respectively). Calculation of odds ratio suggested a 1.7-fold increased risk of vitiligo in individuals having the TA haplotype. We observed overexpression of IFN-γ mRNA with elevated serum levels of IFN-γ, ICAM-1, TNF-α, and TNF-ß in patients with vitiligo when compared with the control group (P = 0.001, for all). In addition, these levels were elevated in patients with active vitiligo compared with stable patients with vitiligo (P = 0.008, 0.006, 0.01, 0.01, and 0.03, respectively), which suggests the involvement of these cytokines in disease activity. In conclusion, IFN-γ is a promising immunological marker in vitiligo pathogenesis.


Asunto(s)
Variación Genética/genética , Inflamación/genética , Interferón gamma/genética , ARN Mensajero/genética , Vitíligo/genética , Vitíligo/patología , Perfilación de la Expresión Génica , Voluntarios Sanos , Humanos , Inflamación/patología , Interferón gamma/sangre
12.
Arab J Gastroenterol ; 17(3): 117-120, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27686263

RESUMEN

BACKGROUND AND STUDY AIMS: Polymorphisms in the DNA repair genes may influence individual capacity to repair DNA damage, which may be associated with increased genetic instability and carcinogenesis. Our aim was to evaluate the relation of genetic polymorphisms in 2 DNA repair genes, XPD Lys751Gln and XRCC1 (A399G), with colorectal cancer (CRC) susceptibility. We further investigated the potential effect of these DNA repair variants on clinicopathological parameters of CRC patients. PATIENTS AND METHODS: Both XPD and XRCC1 polymorphisms were characterised in one hundred CRC patients and one hundred healthy controls who had no history of any malignancy by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) method and PCR with confronting two-pair primers (PCR-CTPP), using DNA from peripheral blood in a case control study. RESULTS: Our results revealed that the frequencies of GG genotype of XRCC1 399 polymorphism were significantly higher in the CRC patients than in the normal individuals (p⩽0.03), and did not observe any association between the XPD Lys751Gln polymorphism and CRC risk. We found association between both XRCC1 A399G polymorphisms and histological grading of disease. CONCLUSION: Our results suggested that, XRCC1 gene is an important candidate gene for susceptibility to colorectal carcinoma.


Asunto(s)
Carcinoma/genética , Neoplasias Colorrectales/genética , Proteínas de Unión al ADN/genética , Proteína de la Xerodermia Pigmentosa del Grupo D/genética , Adulto , Carcinoma/patología , Estudios de Casos y Controles , Neoplasias Colorrectales/patología , Femenino , Frecuencia de los Genes , Predisposición Genética a la Enfermedad/genética , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Clasificación del Tumor , Polimorfismo de Nucleótido Simple , Factores de Riesgo , Arabia Saudita , Proteína 1 de Reparación por Escisión del Grupo de Complementación Cruzada de las Lesiones por Rayos X
13.
IUBMB Life ; 68(9): 727-34, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27346865

RESUMEN

Interferon (IFN)-ß is one of the disease modifying drugs used in the treatment of multiple sclerosis. A predictive marker that indicates good or poor response to the treatment is highly desirable. We aimed to investigate the relation between the immune response genes receptors (IFNAR1, IFNAR2, and CCR5) expression and their polymorhic variants and multiple sclerosis (MS) susceptibility as well as the response to IFN-ß therapy. The immune response genes receptors expression and genotyping were analyzed in 80 patients with MS, treated with IFN-ß and in 110 healthy controls. There was a significant decrease of IFNAR1 and IFNAR2 mRNA expression and a significant increase of CCR5 mRNA expression in MS patients compared with the control group. Also, the level of IFNAR1, IFNAR2, and CCR5 mRNA expression was found to be significantly lower in the responders than nonresponders. Carriers of IFNAR1 18417 C/C genotype and C allele had an increased risk of developing MS. There was a significant relation between CCR5 Δ32 allele and IFN-ß treatment response in MS patients. Our results highlighted the significance of IFNAR and CCR5 genes in multiple sclerosis risk and the response to IFN-ß therapy. © 2016 IUBMB Life, 68(9):727-734, 2016.


Asunto(s)
Esclerosis Múltiple/genética , Receptor de Interferón alfa y beta/genética , Receptores CCR5/genética , Adulto , Alelos , Susceptibilidad a Enfermedades , Femenino , Regulación de la Expresión Génica , Genotipo , Humanos , Inmunidad Innata/genética , Interferón beta/administración & dosificación , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/tratamiento farmacológico , Esclerosis Múltiple/patología , Polimorfismo de Nucleótido Simple , Receptor de Interferón alfa y beta/biosíntesis , Receptores CCR5/biosíntesis
15.
Gene ; 561(1): 107-14, 2015 Apr 25.
Artículo en Inglés | MEDLINE | ID: mdl-25680288

RESUMEN

The present study was designed to investigate whether spermatogonial stem cells (SSCs) have possible effect on doxorubicin (DOX)-induced testicular apoptosis and damaged oxidant/antioxidant balance in rats. Sixty male Albino rats were divided into 3 groups: the saline control group, the testicular toxicity group (2mg/kg DOX once a week for 8 weeks) and the third group is a donor stem cells transplanted following pre-treatment with DOX. After the 8th week, the rats were sacrificed and tissues were collected and examined for CD95, CD95L, Caspase 3, and Caspase 8 gene expression using RT-PCR. While malondialdehyde (MDA), glutathione peroxidase (GSH-Px), catalase (CAT), and superoxide dismutase (SOD) were determined using colorimetric kits. Biochemical, histopathological and PCR results showed improvement of the SSCs' group compared to the DOX-group. It was observed that spermatogonial stem cell affected DOX-induced activation of intrinsic apoptotic signaling pathway via preventing DOX-induced increases in CD95 and CD95L levels as well as cleaved Caspase-8 and Caspase-3 levels in testicular tissues, however, spermatogonial stem cell decreased Dox-induced NF-κB activation as well. It can be concluded that SSCs may be utilized to develop new cell-based therapies, and to advance germline gene therapy.


Asunto(s)
Células Madre Adultas/trasplante , Antibióticos Antineoplásicos/toxicidad , Apoptosis/efectos de los fármacos , Tratamiento Basado en Trasplante de Células y Tejidos/métodos , Doxorrubicina/toxicidad , Animales , Antibióticos Antineoplásicos/farmacología , Caspasa 3/biosíntesis , Caspasa 8/biosíntesis , Catalasa/metabolismo , Doxorrubicina/farmacología , Activación Enzimática , Proteína Ligando Fas/biosíntesis , Expresión Génica , Glutatión Peroxidasa/metabolismo , Masculino , Malondialdehído/metabolismo , FN-kappa B/metabolismo , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos , Ratas , Túbulos Seminíferos/fisiología , Transducción de Señal , Recuento de Espermatozoides , Motilidad Espermática , Recuperación de la Esperma , Espermatozoides/fisiología , Superóxido Dismutasa/metabolismo , Testículo/efectos de los fármacos , Receptor fas/biosíntesis
16.
Gene ; 558(2): 215-9, 2015 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-25560187

RESUMEN

The vitamin D receptor (VDR) is a mediator for the cellular effects of vitamin D and interacts with other cell signaling pathways that influence cancer development. We evaluated the associations of the FOK1 and Taq1 VDR polymorphisms and breast cancer risk and possible effect modification by steroid receptor status of the tumor. This case-control study includes 95 breast cancer patients and 100 age-matched controls. Genotyping for VDR FOK1 and Taq1 polymorphisms was performed using polymerase chain reaction-based restriction fragment length polymorphism. Level of 25(OH)D in serum was determined using ELISA. Immunohistochemical studies were performed for estrogen receptors (ER) and progesterone receptors (PR). The frequencies of ff genotype were significantly increased in the breast cancer group compared to the control group. Carriers of the f allele were significantly more likely to develop BC. We observed a statistically significant interaction for the Fok1 polymorphism and ER status. Our results demonstrated that FOK1 f. genotype and f allele have an important role in breast cancer risk in Saudi patients.


Asunto(s)
Neoplasias de la Mama/genética , Polimorfismo de Longitud del Fragmento de Restricción , Receptores de Calcitriol/genética , Receptores de Estrógenos/metabolismo , Receptores de Progesterona/metabolismo , Adulto , Neoplasias de la Mama/epidemiología , Calcifediol/sangre , Estudios de Casos y Controles , Desoxirribonucleasas de Localización Especificada Tipo II/metabolismo , Femenino , Predisposición Genética a la Enfermedad , Humanos , Persona de Mediana Edad , Arabia Saudita/epidemiología
17.
Gene ; 543(2): 234-6, 2014 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-24720952

RESUMEN

Cyclooxygenase-2 (COX-2) is overexpressed in hepatocellular carcinoma (HCC) and considered to play a role in hepatic carcinogenesis. Our aim was to examine the associations between polymorphisms in COX-2 -765G→C and -1195A→G and risk of HCC. We conducted a case-control study including 120 patients with HCC and 130 age- and gender-matched controls. Genotypes of the COX-2 polymorphisms -765G→C and -1195A→G were determined by polymerase chain reaction-based restriction fragment length polymorphism. No significant difference was observed in the genotype distribution of the -765G→C polymorphism between patients and controls. The -1195AA genotype was associated with an increased risk of developing HCC (OR, 2.5; 95%CI, 1.18-5.37). The A allele was present significantly more often in HCC patients (OR 1.5; 95%CI, 1.05-2.14). In conclusion, our results demonstrated that the -1195AA genotype and A allele have an important role in HCC risk in Egyptian patients.


Asunto(s)
Carcinoma Hepatocelular/epidemiología , Carcinoma Hepatocelular/genética , Ciclooxigenasa 2/genética , Predisposición Genética a la Enfermedad , Neoplasias Hepáticas/epidemiología , Neoplasias Hepáticas/genética , Anciano , Egipto/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple
18.
Cytokine ; 66(2): 101-5, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24594293

RESUMEN

Several cytokines were assumed to play an essential role in the induction and the pathogenesis of psoriasis. The aim of this work was to investigate the role of TNF-α-308 and IL-10-1082 polymorphisms and their serum levels in the pathogenesis of psoriasis and determine their relation to disease severity. 110 Psoriasis patients and 120 healthy volunteers were genotyped for TNF-α-308 and IL-10-1082 polymorphism by polymerase chain reaction. Serum level of TNF-α and IL-10 were measured by ELISA. Our study demonstrated an association of IL-10-1082 polymorphism and psoriasis and between TNF α-308 polymorphism and psoriasis disease and severity. Serum TNF α increased in patients, while serum IL-10 decreased in patients with significant correlation between serum TNF-α and psoriasis severity. These results indicated that TNF-α-308 and IL-10-1082 polymorphisms imparted significant risk towards the development of psoriasis.


Asunto(s)
Interleucina-10/sangre , Interleucina-10/genética , Psoriasis/genética , Factor de Necrosis Tumoral alfa/sangre , Factor de Necrosis Tumoral alfa/genética , Adolescente , Adulto , Anciano , Femenino , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple , Regiones Promotoras Genéticas , Psoriasis/sangre , Psoriasis/epidemiología , Adulto Joven
19.
Res Dev Disabil ; 34(7): 2092-7, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23643763

RESUMEN

Catechol-O-methyltransferase (COMT) plays an important role in the catabolism of brain dopamine and norepinephrine, which have been implicated in the pathogenesis of Autism spectrum disorder (ASD) as well as in other neuropsychatric disorders. We aimed to investigate the association of COMT Val158Met gene polymorphism with ASD and to examine the influence of such genotypes on hyperactivity symptoms in ASD patients. Eighty ASD patients (mean age 9 ± 1.9 years) and 100 control children (mean age 8.9 ± 1.9 years) were examined. COMT Val58Met polymorphism was genotyped using Tetra-primer ARMS-PCR method. The clinical diagnosis of ASD and ADHD were confirmed according to the DSM-IV criteria for research. We found no significant difference in genotypes or alleles' frequencies of COMT Val158Met polymorphism between ASD patients and control group. There was a significant association between COMT (Val/Val) genotype and both increasing CARS (p=0.001) and hyperactivity scores (p=0.006). Regarding Conner's Score, the DSM-IV hyperactive impulsive were significantly higher in Val/Val genotype than both Met/Val and Met/Met genotypes (p=0.03). Our data suggested an association between COMT Val58Met polymorphism and hyperactivity symptoms in Egyptian children with ASD.


Asunto(s)
Catecol O-Metiltransferasa/genética , Trastornos Generalizados del Desarrollo Infantil/genética , Metionina/genética , Valina/genética , Estudios de Casos y Controles , Niño , Egipto , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Genotipo , Humanos
20.
Mol Biol Rep ; 40(5): 3675-80, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23271131

RESUMEN

1α,25-Dihydroxyvitamin D3 upregulates the expression of the receptor activator of nuclear factor kB ligand (RANKL), and downregulates osteoprotegerin (OPG) expression. We tested the effects of polymorphisms in the vitamin D receptor gene (VDR), and OPG gene in rheumatoid arthritis (RA) patients and healthy controls and their relationship to bone mineral density (BMD) and development of osteoporosis. Three hundred and fifty women were evaluated, 200 women having RA and 150 healthy control. The subjects were genotyped for polymorphism at BsmI in VDR and A163G in OPG genes by polymerase chain reaction followed by restriction fragment length polymorphism analysis. BMD was also measured. In A163G, the G allele increased the risk for RA and for the development of osteoporosis. We found a significant association between lower hip (BMD-h) and genotype variants of VDR (BsmI) and OPG A163G in RA patients with osteoporosis. Our results suggested that OPG A163G polymorphism was associated with RA susceptibility and with the development of osteoporosis in these patients. Also, VDR and OPG genes are important candidates for osteoporosis in RA patients.


Asunto(s)
Artritis Reumatoide/complicaciones , Artritis Reumatoide/genética , Osteoporosis/complicaciones , Osteoporosis/genética , Osteoprotegerina/genética , Polimorfismo Genético , Receptores de Calcitriol/genética , Adulto , Alelos , Densidad Ósea/genética , Estudios de Casos y Controles , Egipto , Femenino , Genotipo , Humanos , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA